Pamisell has ranked among the top searched stocks for 9 days in the past month.
As of 10:30 AM on the 19th, Pamisell is trading at 22,700 KRW, down 2.78% from the previous day. This represents a 40.99% increase compared to October 22. Pamisell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.
Today, foreigners are tentatively recorded as net buyers of 13,000 shares. Over the past 5 days, individual investors have been net sellers of 87,832 shares, while foreigners and institutions have been net buyers of 119,885 shares and 11,714 shares, respectively.


※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
